Cancer Immunotherapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ZYME | B | Zymeworks Inc. | 3.12 | |
CRVS | B | Corvus Pharmaceuticals, Inc. | 7.22 | |
CNCR | C | Loncar Cancer Immunotherapy ETF | 3.03 | |
GNTA | C | Genenta Science S.p.A. | 0.00 | |
ARGX | C | argenx SE | -2.40 | |
ACHL | C | Achilles Therapeutics plc | 0.61 | |
BCAB | C | BioAtla, Inc. | -6.38 | |
BCAX | C | Bicara Therapeutics Inc. | 5.71 | |
AVTX | D | Avalo Therapeutics, Inc. | 3.15 | |
TIL | D | Instil Bio, Inc. | -7.30 |
Related Industries: Biotechnology Other
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
EWK | C | iShares MSCI Belgium Capped Investable Market Index Fund | 6.71 | |
MNTL | F | Tema Neuroscience and Mental Health ETF | 4.79 | |
BBH | D | Market Vectors Biotech ETF | 4.41 | |
CANC | D | Tema Oncology ETF | 4.19 | |
FBT | A | First Trust Amex Biotech Index Fund | 3.61 |
Compare ETFs
- Cancer Immunotherapy
Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the system's natural ability to fight cancer. It is an application of the fundamental research of cancer immunology and a growing subspecialty of oncology. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g. carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles